Mazo, G., & Kibitov, A. (2017). Genetic Markers of Metabolic Side-Effects Risks in Second-Generation Antipsychotic Therapy. Current Therapy of Mental Disorders, (4), 2–10. https://doi.org/10.21265/PSYPH.2017.43.8415